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Abstract 
Mytilus edulis is one of the most abundant and widely distributed benthic invertebrate species 
found in the North Atlantic. The aim of this study was to test the applicability of hemocytes from 
Mytilus edulis for in vitro toxicity testing, and quantify the cytotoxic response following 
exposure of the hemocytes to selected PAHs (naphthalene, phenanthrene, pyrene, 
benzo(a)pyrene, 2,6-dimethylnaphthalene, 1,5-/1,7-dimethylphenanthrene). Cell viability was 
assessed with three methods; metabolic activity (measured as alamar blue reduction capacity), 
membrane integrity (measured as 5-carboxyfluorescein diacetate, acetoxymethyl ester reduction 
capacity), and intracellular glutathione level (measured as monochlorobimane binding 
capacity). The use of multiple cytotoxicity endpoints has the advantage of giving possible insight 
into the mechanism of toxicity. 
 In order to identify an optimal medium to maintain the viability of hemocytes in vitro, four 
media were assessed (Leibovitz (L-15), L-15 supplemented with antibiotics, RPMI 1640 and 
phosphate-buffered saline (PBS)). It was decided to culture the cells in L-15 supplemented with 
antibiotics to ensure the aseptic conditions. The hemocytes cultured in the different media 
maintained high viability after 24 hr, 48 hr, and 96 hr, as opposed with those of a 192-hr 
incubation period. 
In this study, DMSO was used as a vehicle for PAHs; therefore the cytotoxicity of three 
DMSO concentrations was examined (0.2%, 0.8%, and 3.2%), in order to avoid its cytotoxic 
effects. The data revealed cytotoxic effect in the 3.2% DMSO treatment, while no cytotoxic effect 
was observed after 0.2% and 0.8% DMSO treatment. 
A general tendency of increasing toxicity with the exposure period was observed by the EC50 
values determined for the tested PAHs. Comparable EC50 values for each time point (24 hr and 
48 hr) were observed from the fluorescent indicator dyes. However, in some cases variable EC50 
values were determined. 
The possible toxic mechanism discussed for each PAH included the following; 1) the 
general membrane disruption (cell membrane and mitochondrial membrane) and loss of 
organelle due to the lipophilic properties of the compounds as in case of naphthalene, 
phenanthrene, and pyrene, 2) the biotransformation role in toxicity and formation of toxic 
metabolites and the lipophilicity were potential mechanisms proposed for benzo(a)pyrene, 3) the 
structure-toxicity relationship was conducted to the subsided PAHs mechanism. By ranking the 
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PAHs cyototoxicity it was found that pyrene and benzo(a)pyrene are the most toxic compounds. 
This study established responses in the cell viability of the blue mussel hemocytes exposed to 
different PAHs. 
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1 Introduction 
1.1 Bivalve molluscs 
Bivalve molluscs are common sentinels widely used in invertebrate toxicology studies. Their 
worldwide distribution combined with their sedentary nature and ability to bioaccumulate 
pollutants as filter-feeders; make them an ideal species for investigation. Most of the studies to 
date have been concerned with the widespread species, the blue mussel, Mytilus edulis (Wootton 
et al., 2003). A range of contaminants including polycyclic aromatic hydrocarbons (Grundy et 
al., 1996) and heavy metals (Coles et al., 1995) have been investigated for their affect on 
hemocytes, using M. edulis as a model organism. In fact, cellular toxicology gives insight and 
understanding of the ecotoxicological processes by elucidation of the mechanisms of action and 
toxicological effects. 
The function of bivalve immune system is to maintain an efficient protection against 
various invaders, however, its efficiency may be weakened by the presence of chemical 
contaminants (Auffret and Oubella, 1997); specifically with the presence of (PAHs) (Gómez-
Mendikute et al., 2002). The bivalve immune system is integrated with other physiological 
systems. Unlike a closed system where lymph and blood function separately, the circulatory 
system in bivalves is an open circulation system with hemolymph containing hemocytes (Reiber 
and McGaw, 2009). Hemolymph, the circulatory fluid of bivalves, transports nutrients, enzymes, 
metabolic wastes, respiratory gases, and toxicants throughout the body. Hence, it can provide 
information on the health assessment of animals or populations (Gustafson et al., 2005). It is 
used in vitro in assessing biomarker responses to environmental stressors, and it is usually 
extracted either via the posterior or anterior adductor muscles (Al-Subiai et al., 2009). The 
hemocytes are found circulating within the hemolymph, and have a vital role in immune system 
such as phagocytosis, as well as their role in cytotoxicity through the production of reactive 
oxygen intermediates. They are a sensitive target for environmental contaminants. Therefore, 
they are frequently used in in vitro studies to assess toxicants interfering with hemocyte 
functions (Grundy et al., 1996; Gagnaire et al., 2006).  
In vitro studies are well-suited for the rapid screening of many pollutants, and for 
providing a significant amount of information about mechanisms of toxicity. Besides, they are 
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inexpensive to carry out. Furthermore, though there is mostly coherence between in vivo and in 
vitro response, the in vitro studies were used as an alternative to the experimentation on animals. 
Thus, they helped limit unnecessary suffering (Devlin et al., 2005). In that respect, it is 
interesting to use a sensitive in vitro laboratory bioassay to measure the response of biomarkers. 
The use of reliable bioassay provides increase in understanding the sensitivity of the cells by 
quantifying the cytotoxic response of the contaminants.  
 
1.2 Cellular methods 
Measuring the cell viability by the fluorometric assays has advantages over other classical 
existing assays (e.g. staining with fluorescent deoxyribonucleic acid (DNA)-specific dyes or 
reduction of tetrazolium compounds). The fluorometric assays can be adapted for a large scale in 
vitro screening and no radioactive or toxic materials are used (Nakayama et al., 1997). In this 
study, cell viability was measured with three fluorescent dyes; alamarBlue
TM 
(AB), 5-
carboxyfluorescein diacetate acetoxymethyl ester (CFDA-AM) and monochlorobimane (mBCI).  
1.2.1 Alamar Blue  
The water-soluble dye alamarBlue
TM 
(AB) has previously been used to quantify in vitro viability 
of various cells (Ahmed et al., 1994; Schreer et al., 2005). AB is a redox indicator with both 
visible color and fluorescence changes in response to the chemical reduction of the medium 
(Shahan et al., 1994). Resazurin, the non-fluorescent oxidized form, is the functional dye in the 
commercial reagent AB. In living cells, resazurin reduces into the fluorescent form resorufin and 
changes its color from blue into pink (Montejano et al., 2005). The conversion is catalyzed by 
reductases, which are found in the mitochondrial membranes, as well as in the cytosol of the 
living cells. The fluorescence reading would therefore be expected to some extent to reflect the 
metabolic activity of cells (Schreer et al., 2005). There are several advantages for using the AB 
assay. AB is added directly to the cells after the incubation period, it is non-toxic to the cells and 
the user. However, it should also be mentioned that the AB fluorescence intensity is sensitive to 
temperature (Nakayama et al., 1997). 
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1.2.2 5-Carboxyfluorescein diacetate acetoxymethyl ester  
The non-fluorescent dye, 5-carboxyfluorescein diacetate acetoxymethyl ester (CFDA-AM), is an 
esterase substrate that can enter living cells and be hydrolyzed by intracellular non-specific 
esterase, to form the highly fluorescent 5-carboxyfluorescein (CF). The substrate diffuses rapidly 
into the cells and the product slowly comes out. The metabolized CFDA-AM can be read 
fluorometrically. The fluorescence reading would reflect the cells membrane integrity. Cells with 
intact plasma membranes would maintain a cytoplasmic environment that supports the activity of 
esterase. An advantage of this assay, is both dyes, the AB and the CFDA-AM, can be used 
alongside each other without interference in the fluorescent measurements because the two 
probes are measured at different emission wavelengths (Schirmer et al., 1997; Schreer et al., 
2005). 
1.2.3 Monochlorobimane  
Glutathione (GSH) is the main non-protein thiol in the cells and plays a critical role in defense 
and detoxification. All of the main biological events that entail the thiol-redox state contain GSH 
interactions. Some examples include DNA synthesis, signal transduction and gene transcription. 
A low GSH level in the hemolymph indicates signs of oxidative stress (Esteban-Pretel and Pilar 
López-García, 2006).  
In order to bind free thiols, monochlorobimane is used. It is a cell permeable non-
fluorescent dye. It forms a fluorescent adduct with GSH in a reaction catalyzed by GSH S-
transferase. Monochlorobimane fluorescence is used as an indirect indicator of GSH 
concentration (Fernández-Checa and Kaplowitz, 1990). 
 
1.3 Polycyclic aromatic hydrocarbons (PAHs) 
All over the world, the marine environment is continuously polluted by oil spillage from tanker 
accidents, natural seepage, and releases from offshore production (Saeed and Al-Mutairi, 2000). 
Therefore, a notable environmental issue is coastal pollution by chemical contaminants such as 
hydrocarbons. M. edulis is usually used as an indicator of habitat exposure to organic 
contaminants in coastal waters. It assesses the status of chemical contaminants (Chase et al., 
2001). As one example, Bocquené et al. (2004) carried out a 3-year survey in situ using various 
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biological markers in M.edulis exposed to oil that came ashore after the French “Erika” oil spill 
in December 1999.  
Crude oil is a complex mixture of PAHs, phenols, and heterocyclic compounds containing 
sulphur and nitrogen (Saeed and Al-Mutairi, 2000). PAHs compounds contribute most to the 
toxicity of most oils (Koyama and Kakuno, 2004). PAHs are a family of hydrocarbons 
containing two or more fused aromatic ring structures (benzene), in linear angular or cluster 
arrangement (Brown et al., 1996). The PAHs range from the simple two-fused benzene ring like 
naphthalene (C10H8), to complex hydrocarbons such as the seven-fused ring, coronene (C24 H12) 
(Manoli and Samara, 1999).  
There are natural and anthropogenic sources of PAHs, originating from multiple processes 
such as biogenic, petrogenic, and pyrogenic processes (Spink et al., 2008). The natural sources 
arise from biogenic precursors that are common constituents of terrestrial higher plants in the 
digenetic process (Magi et al., 2002). The anthropogenic sources originated from either 
petrogenic or pyrogenic processes. PAHs from petrogenic sources derive from petroleum 
products. While in the case of pyrogenic process, they are derived from incomplete combustion 
processes in industrial operations, power plants, and so forth (e.g. petroleum, vehicle emissions, 
wood, coal, etc.) (Saha et al., 2009). Direct sources of PAHs in the marine environment comprise 
of oil spills, sewage, and runoff from roads.  
Many propose the term „baseline toxicity‟ to assess the process of chemicals that elicit 
their toxicity by interfering with membrane fluidity. Seventy percent of all commercial 
chemicals have this property including the PAHs (Engraff et al., 2011). PAHs are also a group of 
organic compounds which are of major concern due to the documented carcinogenicity in many 
experiments of several of its members (Manoli and Samara, 1999).  
The US Environmental Protection Agency (E.P.A.) has identified 16 unsubstituted PAHs 
as priority pollutants (Manoli and Samara, 1999). In the current study, the cytotoxicity of four 
PAHs, naphthalene, phenanthrene, pyrene, and benzo(a)pyrene, that are selected by the E.P.A. 
and two substituted PAHs, 2,6-dimethylnaphthalene and 1,5-/1,7-dimethylphenanthrene, were 
measured in the hemocytes of blue mussel.  
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1.4 Objective 
The overall aim of the study was to optimize the use of isolated hemocytes from blue mussels 
(Mytilus edulis) for in vitro testing and to quantify the cytotoxic response following exposure to 
selected PAHs.  
 
The following questions were investigated:  
 
1. What are the optimal cell medium and density for the hemocytes of blue mussels to be 
used for in vitro testing?  
2. Is DMSO toxic to hemocytes at concentrations used in in vitro tests? 
3. What is the cytotoxicity of selected PAHs (naphthalene, phenanthrene, pyrene, 
benzo(a)pyrene, 2,6-dimethylnaphtalene, and 1,5-/1,7-dimethylphenantrene) to blue 
mussel hemocytes measured as metabolic activity, membrane stability and intracellular 
glutathione level? 
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2 Materials and Methods 
2.1 Collection of animals and sampling area 
Blue mussels are found along the entire coast of Norway. The sample was collected from the 
University‟s marine biological station of Drøbak. The city lies 40 kilometers south of Oslo, 
Norway, located in the outer Oslofjord.  
Mussels were collected of both sexes and similar size (shell length 6 ± 1.5 cm). After 
collection, they were immediately transported to Oslo University in plastic bags. The mussels 
were placed in each of two 6 liter plastic tanks, which were continuously aerated. The water was 
changed every day before feeding, to ensure water quality parameters. The mussels were fed 
regularly, around once per week, with Shellfish-diet 1800 (Isochrysis, Pavlova, Tetraselmis, 
Thalassiosira weissflogii) and kept at a constant temperature of 10ºC until extraction of 
hemolymph. 
 
2.2 Buffers, solutions and media 
2.2.1  Culture media 
Phosphate Buffered Saline (PBS) was prepared by dissolving the following: 23.2 g of NaCl, 1.48 
g of Na2HPO4, 0.43 g of KH2PO4 in 1 liter Milli-Q water. 1 M NaOH was added to the mixture 
and the pH was fixed at 7.4. 
Leibovitz‟ medium was purchased from Biowhittaker. The antibiotic that consists of penicillin 
(100 Units/mL), streptomycin (100 µg/L) and amphotericin (0.25 µg/L) was added to L-15 
medium. 
2.2.2 Preparation of the cytotoxicity probes and buffer 
Tris buffer (50 mM, pH 7.5) is a dye working solution containing 11.6 µL CFDA-AM stock 
solution, 579 µL AB, and 11 µL cytotoxic buffer. The solution was every time prepared every 
time immediately prior to use.  
The cytotoxic buffer was prepared by adding 0.97 g of trizma-base and 6.61 g trizma-HCL in 1 
liter of distilled water. The pH was adjusted to 7.5. CFDA-AM stock solution consists of 5 mg 
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CFDA-AM and 2.35 mL DMSO. While the mBCI stock solution consisted of 25 mg mBCI and 
1.82 mL DMSO. CFDA-AM and mBCI were kept frozen until use. Alamar blue was purchased 
as a ready-to-use solution and kept refrigerated. 
 
2.3 Preparation of hemocytes 
2.3.1 Extraction of the hemolymph 
The hemolymph was withdrawn from the posterior adductor muscle of the mussels. To access 
the posterior adductor muscle and to prevent the bivalves from completely closing their two 
shells, a solid scalpel was inserted between the two shells and with gentle prising, the shell was 
opened. Seawater was drained from the mantle cavity to ensure that there was no possibility of 
accidentally drawing up seawater. During this process, the mussel was held with the posterior 
upwards, and with the anterior resting on a bed of paper towel. The protocol for hemolymph 
extraction was adapted from (Coray et al., 2007) with minor changes: The hemolymph was 
extracted using a sterile 1 mL syringe, with a 23-gauge needle, which was pretreated with cold 
phosphate buffered saline (PBS). Most collections yielded 0.5 mL hemolymph from each 
mussel. The colorless hemolymph was then immediately transferred to cooled sterile tissue 
culture tubes (Falcon), containing 0.l mL PBS. It was aliquotted and mixed 50:50 
(hemolymph/PBS with 10 mM EDTA) and vortexed for about 3 seconds. All the work was 
maintained on ice to avoid hemocyte clumping. 
2.3.2 Quantification of hemocytes – viability assay 
The viability of the freshly collected hemocytes was quantified microscopically by the use of 
trypan blue exclusion (Pappenheimer, 1917). In eppendorf vials, two parts of trypan blue were 
mixed with one part of the cells suspension (20 µL + 10 µL). Live cells will exclude the dye due 
to their intact membranes, while oppositely dead cells do, appearing blue under the microscope. 
Trypan blue requires manual cell counting by using the embedded grid of a hemocytometer. 
Therefore, cells were located using a microscope with a lens magnification of 40x, and hemocyte 
counts were recorded using the Bürker-Türk (BT) haemocytometer. 
The hemocytes were further diluted with Leibovitz‟s medium supplemented with 
antibiotics (L-15(+)) (see Section 2.2.1) to hold a concentration of 200 000 cells/mL. The cells 
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were then seeded out into 96-well Costar® cell culture plates (Corning labware, NY, USA), 200 
µL of the suspensions to each well. The microtiter plates were put in an incubation chamber at 
10ºC. The different plates were incubated for 24 hr, 48 hr, 96 hr and 192 hr, respectively.  
 
2.4 In vitro exposure of hemocytes 
Prior to assessment of cytotoxicity (Section 2.5) within 24 hr, half of the culture medium (100 
µL) was replaced with the exposure solution (Ellesat et al., 2010), to give a total volume of 200 
µL per well. The exposures consisted of varying concentrations of the test compounds dimethyl 
sulfoxide (DMSO) and PAHs.  
 
2.5 Cytotoxicity assays  
The cytotoxicity assay was carried out using the exposed cells. The assay was applied both 
during establishment of cell culture conditions and during the toxicity test studies. The procedure 
was the same for all experiments. The protocol was adapted from (Schirmer et al., 1998).  
To assess the cytotoxicity, all culture media were removed from each well and 100 µL of Tris 
buffer (Section 2.2.2) was added. The microtiter plates were incubated at room temperature on 
an orbital table shaker at 100 rpm for 30 minutes. Due to the dyes‟ sensitivity to light, every step 
of this protocol was carried out in the dark. The fluorescence plate reader was set to excitation 
and emission wavelength pairs of 540-590 nm (AB), 485-530 (CFDA-AM). The fluorescence 
was then set to excitation and emission wavelength pairs of 360-460 for the third measurement 
(mBCI). After conducting readings, the average of the blank (culture media) was calculated and 
subtracted from the data. 
 
2.6 Reference toxicity 
As a reference for toxicity, copper as CuSO4 x 5H2O was used in this study. Thus, a 2-fold serial 
dilution was performed from the stock solution of 5 mg/mL copper to obtain the following 
concentrations: 2.5, 1.25, 0.625, 0.313, 0.156, 0.078, 0.039, and 0.019 mg/mL. Stock solutions 
were prepared in the culture medium L-15(+). 
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2.7 Optimization of cell culture density and medium 
2.7.1 Optimization of cell density 
Seeding out the different cell concentrations, 100 000, 200 000, and 400 000 cells/mL assessed 
the effect of cell-seeding density on hemocyte viability. The cells were seeded out into 96-well 
Costar® cell culture plates.  
Four replicates were used, each of which consisted of hemolymph from five mussels. The 
hemolymph extraction and the viability assay were carried out as mentioned above (Sections 
2.3.1 and 2.3.2). Nevertheless there were minor changes in the viability assay: Rather than 
diluting the hemocytes to hold a concentration of only 200 000 cells/mL of medium, two other 
hemocyte concentrations were screened in parallel. Those were 100 000 and 400 000 cells/mL of 
medium; to determine which hemocyte concentration would perform best. The microtiter plates 
were placed under the microscope and pictures were taken. 
2.7.2 Optimization of culture media 
Four media were assessed for their ability to maintain viability of hemocytes in vitro: L-15, L-
15(+), RPMI, and PBS. Autoclaving was used for sterilization of media. This experiment was 
not only conducted to screen multiple media, but also to function as a platform for the following 
two experiments. 
Five replicates were used, each of which consisted of hemolymph from five mussels. The 
hemolymph extraction and the viability assay were carried out as mentioned above (Sections 
2.3.1 and 2.3.2), although with minor changes in the viability assay: Instead of diluting 
hemocytes with one medium, four different media were screened in parallel to determine which 
medium would perform best with the hemocytes. The hemocytes were incubated for 24 hr, 48 hr 
96 hr, and 192 hr prior the cytotoxicity measurement. Effects of the media on hemocytes count 
and viability were analyzed by the cytotoxicity assays (Section 2.5). 
 
2.8 Cytotoxicity of DMSO 
It was of great importance to test the optimal DMSO concentration, to avoid its cytotoxic side 
effects. This was achieved by determining the maximal concentration usable for the cell 
viability. Various DMSO concentration test samples were prepared by slowly adding 5, 20, and 
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80 μL of DMSO to 2495, 2480, 2420 μL of L-15(+) media, respectively, to reach a final volume 
of 2500 μL and DMSO concentrations of 0.2%, 0.8%, and 3.2%, respectively. 
Five replicates were used, each of which consisted of hemolymph from five mussels. The 
hemolymph extraction and the viability assay were carried out as mentioned above (Sections 
2.3.1 and 2.3.2), and in vitro exposure of hemocytes were executed as mentioned (Section 2.4). 
The incubation periods were 24 hr, 48 hr, and 96 hr. Prior to assessment of cytotoxicity within 
24 hr, half of the media and cells were removed, and 100 µL of the three different DMSO 
concentrations (0.2%, 0.8%, and 3.2%) were added to the microtiter plates. Effects of DMSO 
exposure on cell viability and hemocyte count were assessed by the cytotoxicity assays (Section 
2.5). Copper was used as a reference for toxicity (Section 2.6). 
 
2.9 Cytotoxicity of PAHs 
The cytotoxicity assays were performed to determine the cytotoxic effect of six PAHs 
compounds on the hemocytes. Based on 50% lethal concentration (LC50) for fish (ATSDR, 
2009), 8 serial four-fold dilutions of each compound were prepared in 0.2% DMSO diluted in L-
15(+) medium. The experiment protocol was carried out based on the outcome of the cell density 
and culture media optimization (Sections 2.7.1 and 2.7.2), as well as the best DMSO 
concentration performance (Section 2.8). 
Three replicates were used, each of which consisted of hemolymph from five mussels. The 
hemolymph extraction, viability assay, and in vitro exposure of hemocytes were conducted as 
mentioned above (Sections 2.3.1, 2.3.2, and 2.4). The incubation lasted for 24 hr and 48 hr. Prior 
to assessment of cytotoxicity within 24 hr, half of the media and cells were removed and 100 µL 
of the eight different PAHs concentrations were added to the 96-well microtiter plates. Effects of 
PAHs exposure on cell viability and hemocyte count were analyzed by the cytotoxicity assays 
(Section 2.5). Copper was used as a reference for toxicity (Section 2.6). 
 
 2.10 Statistical procedures  
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software Inc., San Di-
ego, CA, USA). Kruskal–Wallis test followed by Dunns test was used for evaluating differences 
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between groups whenever variances between groups were not homogenous. The Wilcoxon test 
was used to determine which treatment groups differed from the control. Bonferroni correction 
was used wherever applicable (repeated tests with the same group, e.g. control against treat-
ments). Wherever the data allowed, a four-parameter logistic regression was used to fit a line to 
toxicity data for each PAH at the two time points. The significance level was set to p ≤0.05 for 
rejection of H0 in all analyses. 
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3 Results 
3.1 Cell density optimization 
Microscope examination was completed immediately after extracting and mixing the hemocytes 
with L-15(+) medium to reach the different cell concentrations (100 000, 200 000, and 400 000 
cells/mL). The examination revealed a variety of single and aggregated cells, which exhibited 
different sizes due to various cell concentrations in the media. This is displayed below in Figure 
1. At the concentration of 100 000 cells/mL the total number of hemocytes was low and no 
aggregation was obtained (Figure 1a). At concentration 200 000 cells/mL more and separated 
hemocytes were observed (Figure 1b). On the contrary, hemocytes at concentration 400 000 
cells/mL had a roughly circular spontaneous aggregation (Figure 1c). Hence, the cell density of 
200 000 cells/mL was chosen for the following cytotoxicity measurements. 
a)                                                                                                b) 
  
                                                               c) 
 
 
Figure 1. Representative micrographs of hemocytes from Mytilus edulis seeded out at a concentrations of (a) 
100 000, (b) 200 000 and (b) 400 000 cells/mL.  The hemocytes were mixed with L-15(+) as a cell culture (n=5). 
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3.2 Cell medium 
3.2.1 Metabolic activity 
The optimization of the cell medium was performed by testing L-15, L-15(+), RPMI, and PBS as 
a culture media for the hemocytes. Between the hemocytes cultured in the assorted media, a 
variance in fluorescence was observed after the incubation periods of 48 hr (p=0.004, Kruskal-
Wallis) and 96 hr (p=0.0001, Kruskal-Wallis). Comparing this differentiation in rank sum, for 
each two media, highlighted the difference. The hemocytes cultured in L-15 had higher 
metabolic activity compared with those cultured in L-15(+), RPMI and PBS media after 48 hrs 
and 96 hrs incubation (p<0.005, Dunn‟s test) (Figure 2).  
There was a correlation between increasing the incubation period and decreasing the 
metabolic activity of cells in each medium. The difference was observed between cultures of 24 
hr and 192 hr of incubation. The 24 hr incubation had the highest metabolic activity compared to 
that of 192 hr for all the media (p<0.005, Dunn‟s test). There was no significant difference 
observed between the viability data after 24 hr, 48 hr, and 96 hr incubation periods (Figure 2). 
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Figure 2. Metabolic activity of hemocytes held in L-15 (pink), L-15(+) (grey), RPMI (blue) or PBS (yellow). 
Cytotoxicity was measured following 24 hr, 48 hr, 96 hr, and 192 hr incubation periods. Cell viability decreased 
with increasing the incubation periods. The lowest cell viability was observed after 192 hr (*) incubation period 
(n=5). 
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3.2.2 Membrane integrity 
There were differences in fluorescence between the media data following incubation periods of 
48 hr (p=0.0003, Kruskal-Wallis) and 96 hr (p=0.0006, Kruskal-Wallis) (Figure 3). The 
hemocytes cultured in the L-15 had higher membrane integrity than those cultured in the other 
three media (p<0.005, Dunn‟s test). 
The length of exposure (24 hr, 48 hr, 96 hr and 192 hr) caused significantly different 
effects on the cell viability for each medium (L-15 (p<0.0001, Kruskal-Wallis), L-15(+) 
(p<0.0001, Kruskal-Wallis), RPMI (p<0.0001, Kruskal-Wallis), and PBS (p<0.0001, Kruskal-
Wallis)). When comparing the incubation periods, the 24 hr media and cells incubation had the 
highest membrane integrity compared to that of 192 hr (L-15, L-15(+), RPMI, and PBS 
(p<0.005, Dunn‟s test)) (Figure 3). 
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Figure 3. Membrane integrity of hemocytes held in L-15 (pink), L-15(+) (grey), RPMI (blue) or PBS (yellow). 
Cytotoxicity was measured following 24 hr, 48 hr, 96 hr, and 192 hr incubation periods. Cell viability decreased 
with increasing the incubation periods. The lowest cell viability was observed after 192 hr (*) incubation period 
(n=5). 
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3.2.3 Glutathione concentration 
There were differences in the hemocyte glutathione concentration between the media following 
the incubation periods: 48 hr (p=0.004, Kruskal-Wallis), 96 hr (p<0.0001, Kruskal-Wallis), and 
192 hr (p=0.0002, Kruskal-Wallis) (Figure 4). The highest glutathione concentration was found 
in hemocytes cultured in L-15 medium after 48 hr and 192 hr (p<0.005, Dunn‟s test). 
There was a correlation between increasing the incubation periods and decreasing the 
glutathione content of hemocytes that cultured in each medium (L-15 (p<0.0001, Kruskal-
Wallis), L-15(+) (p<0.0001, Kruskal-Wallis), RPMI (p<0.0001, Kruskal-Wallis), and PBS 
(p<0.0001, Kruskal-Wallis)). The 24 hr incubation had the highest glutathione concentration 
compared to 48 hr, 96 hr, and 192 hr incubation (p<0.005, Dunn‟s test). While, the results for 
192 hr incubation were the lowest compared to all the other incubation peroids (p<0.005, Dunn‟s 
test) (Figure 4). 
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Figure 4. Glutathione content of hemocytes held in L-15 (pink), L-15(+) (grey), RPMI (blue) or PBS (yellow). 
Cytotoxicity was measured following 24 hr, 48 hr, 96 hr, and 192 hr incubation periods. Cell viability decreased 
with increasing the incubation periods. The lowest cell viability was observed after 192 hr (*) incubation period 
(n=5). 
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3.3 DMSO concentrations  
3.3.1 Metabolic activity 
As seen in Figure 5, the metabolic activity of the hemocytes seemed be unaffected after 
treatment with 0.2% and 0.8% DMSO concentrations at all of the incubation periods (24 hr, 48 
hr, and 96 hr) compared to the control. The only observed effect was from the exposure to 3.2% 
DMSO concentration, which decreased the metabolic activity after 24 hr, 48 hr, and 96 hr 
(p*=0.001, p*=0.0001, and p*=0.0001, respectively, Wilcoxon test) compared to the same 
incubation periods of the control. 
 Increasing the incubation period caused decreasing in the metabolic activity. There was a 
difference between hemocytes exposed to 0.2%, 0.8%, and 3.2% DMSO after 24 hr (p=0.003, 
Kruskal-Wallis), 48 hr (p=0.0003, Kruskal-Wallis), and 96 hr (p=0.001, Kruskal-Wallis) of 
incubation. 
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Figure 5. The effect of (0.2%, 0.8%, 3.2%) DMSO on the metabolic activity of the hemocytes. The hemocytes 
were incubated for 24 hr (pink), 48 hr (blue), and 96 hr (yellow) before the cytotoxicity assessment. The cells 
were maintained for 24 hr before they were exposed to the different DMSO concentrations (n=5). 
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3.3.2 Membrane integrity 
The membrane integrity of the hemocytes appeared to be unaffected at 0.2% and 0.8%, DMSO 
concentrations compared to the control. The only observed effect was from the exposure to 3.2% 
DMSO concentration, which decreased the membrane integrity after 24 hr, 48 hr, and 96 hr 
(p*=0.0002, p*=0.0001, and p*=0.0001, respectively, Wilcoxon test) compared to the same 
incubation periods of control (Figure 6). 
 The fluorescence of hemocytes incubated with 0.2%, 0.8%, and 3.2% DMSO varied after 
24 hr (p=0.0008, Kruskal-Wallis), 48 hr (p=0.0005, Kruskal-Wallis), and 96 hr (p=0.0009, 
Kruskal-Wallis) of incubation. 
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Figure 6. The effect of (0.2%, 0.8%, 3.2%) DMSO on the membrane integrity of the hemocytes. The hemocytes 
were incubated for 24 hr (pink), 48 hr (blue), and 96 hr (yellow) before the cytotoxicity assessment. The cells 
were maintained for 24 hr before they were exposed to the different DMSO concentrations (n=5). 
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3.3.3 Glutathione concentration 
The data of glutathione concentration did not show any significant difference at the tested 
concentrations of DMSO (Figure 7). 
 However, a difference occurred in data of hemocyte glutathione content exposed to 0.2%, 
0.8%, and 3.2% DMSO after 48 hr (p=0.02, Kruskal-Wallis) and 96 hr (p<0.0001, Kruskal-
Wallis) of incubation.  
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Figure 7. The effect of (0.2%, 0.8%, 3.2%) DMSO on the glutathione concentration of the hemocytes. The 
hemocytes were incubated for 24 hr (pink), 48 hr (blue), and 96 hr (yellow) before the cytotoxicity assessment. 
The cells were maintained for 24 hr before they were exposed to the different DMSO concentrations (n=5). 
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3.4 PAH cytotoxicity 
3.4.1 Naphthalene cytotoxicity 
Cells exposed to different naphthalene concentrations had a decrease in cell viability in a dose 
dependent manner (Figure 8). The 24 hr EC50 (half maximal effective concentration of 
naphthalene) for metabolic activity was higher (7.9×10
-5
 mg/L) than that of 48 hr (1.9×10
-5
 
mg/L). An increase in 24 hr EC50 (9.9×10
-1
 mg/L) for membrane integrity was observed 
comparing to the EC50 for the other probes. The 24 hr EC50 for glutathione content was (3.1×10
-3
 
mg/L) (Table 1).  
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Figure 8. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to naphthalene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, f) prior to 
assessment of cytotoxicity (mean ± SEM, n = 3). R
2
= 0.8, 0.26 (AB), 0.38, 0.23 (CFDA-AM), 0.27, not computed 
(mBCI), at 24 hrs and 48 hrs, respectively. 
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3.4.2 Phenanthrene cytotoxicity 
The data showed that phenanthrene caused a dose dependent cytotoxicity (Figure 9). For all the 
probes, the 48 hr EC50 was lower than that of 24 hr exposure. The 24 hr EC50 values for 
metabolic activity and membrane integrity were (6.3×10
-4
 and 7.9×10
-4
 mg/L). At the same time 
point the EC50 for glutathione content was (1.0×10
-5
 mg/L). After 48 hr, the EC50 values for 
membrane integrity and glutathione content were lower (1.9×10-5 and 2.5×10-6 mg/L), respectively 
(Table 1). 
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Figure 9. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to phenanthrene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, f) prior to 
assessment of cytotoxicity (mean ± SEM, n = 3). R
2
= 0.28, not computed (AB), 0.54, 0.32 (CFDA-AM), and 0.21, 
0.37 (mBCI), at 24 hr and 48 hr, respectively. 
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3.4.3  2,6-Dimethylnaphthalene 
There was a concentration dependent decrease of cell viability following exposure to increasing 
concentrations of 2,6-dimethylnaphthalene (Figure 10). The 24 hr EC50 values were higher than 
48 hr EC50 for the probes measured. With a 24 hr exposure, EC50 value of (3.0×10
-2
 mg/L) was 
obtained for metabolic activity and membrane integrity. After 48 hr exposure the EC50 were 
lower for metabolic activity and membrane integrity (3.9×10
-5 
and 6.3×10
-5
 mg/L) (Table 1). 
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Figure 10. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to 2,6-dimethylnaphthalene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, f) prior 
to assessment of cytotoxicity (mean ± SEM, n = 3). R
2
= 0.70, 0.38 (AB), 0.70, 0.13 (CFDA-AM), and 0.26, 0.26 
(mBCI), at 24 hr and 48 hr, respectively. 
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3.4.4  1,5-/1,7-Dimethylphenanthrene 
A cell viability reduction was observed after exposure the hemocytes to 1,5-/1,7-
dimethylphenanthrene (Figure 11). In general, the 24 hr EC50 values were higher than those for 
the 48 hr exposure. The EC50 obtained after 24 hr were 1.0×10
-3
, 1.9×10
-2 
and
 
1.0×10
-2 
mg/L for 
metabolic activity, membrane integrity and glutathione content, respectively, with lower values 
after a 48 hr exposure period (Table 1). 
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Figure 11. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to 1,5-/1,7-dimethylphenanthrene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, 
f) prior to assessment of cytotoxicity (mean ± SEM, n = 3). R
2
= 0.44, 0.25 (AB), 0.39, not computed (CFDA-AM), 
and 0.26, 0.50 (mBCI), at 24 hr and 48 hr, respectively. 
 
 
 
30 
 
3.4.5 Pyrene 
The results showed that the cell viability was reduced in a dose responsive manner after exposure 
the hemocytes to pyrene (Figure 12). The 48 hr EC50 values were lower than those of 24 hr for 
each of the fluorescent indicator dyes.The same 24 hr EC50 (5.0×10
-5
 mg/L) was observed for the 
metabolic activity and membrane integrity. The 48 hr EC50 values determined for membrane 
integrity and intracellular GSH concentration were (6.3×10
-7 
and 1.5×10
-6
). Apparent metabolic 
activity appeared to decrease from 24 (5.0×10
-5
 mg/L) to 48 hr (1.9×10
-13
 mg/L). 
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Figure 12. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to pyrene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, f) prior to assessment of 
cytotoxicity (mean ± SEM, n = 3). R
2
= 0.69, 0.61 (AB), 0.62, 0.26 (CFDA-AM), and not computed, 0.46 (mBCI), at 
24 hr and 48 hr, respectively. 
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3.4.6 Benzo(a)pyrene 
The data showed that benzo(a)pyrene caused a dose dependent cellular cytotoxicity (Figure 13). 
Comparable results for each time point were observed for the three probes. The 24 hr EC50  
 was higher than that for 48 hr for all the probes measured. The EC50 values for metabolic 
activity and membrane integrity were (1.0×10
-5
 and
 
1.2×10
-5
 mg/L), respectively after 24 hr 
incubation. At the second time point the EC50 values for metabolic activity and glutathione 
content were (5.0×10
-7 
and
 
1.9×10
-7 
mg/L), respectively (Table 1). 
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Figure 13. Metabolic activity (a, b), membrane integrity (c, d), and glutathione content (e, f) in the hemocytes 
following exposure to benzo(a)pyrene. The cells were exposed for 24 hr (a, c, e) and 48 hr (b, d, f) prior to 
assessment of cytotoxicity (mean ± SEM, n = 3). R
2
= 0.76, 0.53 (AB), 0.80, not computed (CFDA-AM), and not 
computed, 0.17 (mBCI), at 24 hr and 48 hr, respectively. 
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Table 1. Summary of PAHs EC50  
 
           Probe 
 
         PAH 
AB 
24 hr 
(EC50) 
CFDA-AM    
24 hr 
(EC50) 
mBCI 
24 hr  
(EC50) 
AB 
48 hr 
(EC50) 
CFDA-AM   
48hr 
(EC50) 
mBCI 
48hr 
(EC50) 
Naphthalene 7.9×10-5 9.9×10-1 3.1×10-3 1.9×10-5 1.5×10-3 * 
Phenanthrene 6.3×10-4 7.9×10-4 1.0×10-5 * 1.9×10-5 2.5×10-6 
2,6-Dimethylnaphthalene 3.0×10-2 3.0×10-2 2.0×10-2 3.9×10-5 6.3×10-5 3.0×10-2 
1,5-/1,7-
Dimethylphenanthrene 
1.0×10
-3
 1.9×10
-2
 1.0×10
-2
 2.5×10
-5
 * 1.5×10
-3
 
Pyrene 5.0×10-5 5.0×10-5 * 1.9×10-13 6.3×10-7 1.5×10-6 
Benzo(a)pyrene 1.0×10-5 1.2×10-5 * 5.0×10-7 * 1.9×10-7 
 
The EC50 (mg/L) of the cytotoxic activity of PAHs determined after 24 hr and 48 hr exposure of hemocytes.   
(* = not computed). 
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4 Discussion 
4.1 Cell density optimization 
Cell aggregation is a term used to describe hemocytes as they become sticky and attach to one 
another and foreign surfaces. It is a spontaneous event that could occur either with the isolation 
of hemolymph from mussels or immediately afterwards. This phenomenon was studied 
previously in vitro by Chen and Bayne (1995) using Mytilus californianus hemocytes. In the 
present study, cell aggregation was observed at a concentration of 400 000 cells/mL, whereas 
cells remained dispersed at lower cell densities (100 000 and 200 000 cells/mL). 
Cell density of 400 000 cells/mL was not the optimal cell density in this study because of 
the potential adverse effects that might occur from the resulting cell aggregation. For instance, 
cell aggregation could provoke stress and thus reduce the cell survival rate. The coagulation of 
hemocytes reduces stimulation after exposure to the stressors is another likelihood. Additionally, 
it's possible that the high cell density results in the inability of cells to attach themselves onto the 
microtiter plates. Thus, they are removed by the addition of the probes. Therefore, measuring 
cell viability at a density of 400 000 cells/mL was not applicable. On the other hand, testing with 
a cell density of 100 000 cells/mL, yielded a lower cell count. This density was not 
recommended either, because it might lead to lower response. Hence, the density of 200 000 
cells/mL is the most practical one in this study. 
 
4.2 Cell medium optimization 
Four culture media (L-15, L-15(+), RPMI, and PBS) were tested for their ability to maintain the 
viability of hemocytes in vitro. The four media gave almost comparable results. Cell viability in 
terms of metabolic activity, membrane integrity and glutathione content decreased with 
increasing the incubation periods (24 hr, 48 hr, 96 hr and 192 hr). 
Pervious study reported that the isolated cells from the zebra mussel maintained in L-15 
medium survived better than those in RPMI (Quinn et al., 2009). In fact, L-15 culture medium, 
containing salts, galactose, and pyruvate (Leibovitz, 1963), has been suggested to be the most 
appropriate medium for M.edulis hemocytes cell culture (Hartl et al., 2010). Nevertheless, it was 
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decided to culture the cells in L-15(+). This medium provided satisfactory results in the 
cytotoxicity assays. Since hemocytes proliferate upon infection (Arala-Chaves and Sequeira, 
2000), adding antibiotics to the medium ensures the aseptic conditions by minimizing the 
potential bacterial contamination (Wenli and Shields, 2007). However, the amphotericin B added 
to the L-15(+) medium could affect hemocytes negatively by decreasing their viability (Cao et 
al., 2003). On the other hand, PBS medium was not recommended as cell culture. This may be 
due to the isoosmotic detrimental effect of PBS medium that could occur. 
The hemocytes cultured in the different media tested maintained high viability after 24 hr, 
48 hr, and 96 hr, as opposed with those of a 192-hr incubation period. This is in accordance with 
the findings of Li and Shields (2007), who cultured the hemocytes of lobster in L-15, RPMI, and 
other media. Those tests suggest that the hemocytes survived, but did not proliferate in any of the 
used culture media. Based on this assumption, several attempts have been made to establish 
permanent and proliferated cell cultures from marine invertebrates, yet they have been 
unsuccessful (Rinkevich, 1999). 
In summary, to maintain the cell culture and ensure the aseptic conditions, the use of L-
15(+) medium seemed to be a more suitable medium for hemocytes of the blue mussel in this 
study, with an incubation period up to four days.  
 
4.3 DMSO cytotoxicity 
DMSO is a carrier solvent, which represents a reliable approach to dissolve PAHs. The latter are 
poorly soluble in media since they are hydrophobic compounds. In this case and in absence of 
other alternatives, DMSO as a carrier solvent is used. In this study, PAHs were diluted in 
DMSO. Therefore, a DMSO cytotoxicity test had to be conducted, to ensure a safe concentration 
to dissolve the PAHs. 
In this study, cell viability measurements of hemocytes cultured in 0.2% and 0.8% DMSO 
concentrations were not significantly different from those of the control. When cultured in 3.2% 
DMSO concentration, cell viability was lower than control. 
The results indicated that a concentration of 0.2% DMSO was the most suitable to be used 
as a vehicle for PAHs. Cultures treated with 0.8% DMSO appeared to have a cytotoxic tendency 
(although not significant) and those treated with 3.2% DMSO had lower number of cells 
compared to control. These results are in accordance with a study on mammalian cells, showing 
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cytotoxic effects of DMSO at concentrations between 0.5% and 6% with little or no damage at 
concentrations up to 0.1% (Qi et al., 2008). This may indicate that the blue mussel hemocytes 
are almost as sensitive as mammalian cells. Conversely, several studies on fish use up to 1% 
DMSO concentration without any reported deleterious effects (Bell et al., 1981; Kammann et al., 
2001). 
Kontir et al. (1986) performed an evaluation of different vehicles (such as DMSO, acetone, 
methanol and ethanol), measuring the effect of BaP metabolism in rabbit lung microsomes. 
DMSO caused a less harmful effect on BaP metabolism. In fact, the toxicity of DMSO may be 
related to its action on the stability of cell membranes (Yu and Quinn, 1994). 
Taken together, to avoid the potential cytotoxic side effects of DMSO the suitable DMSO 
concentration usable in this study appeared to be 0.2%, which agrees with a previous study by 
Chen and Bayne (1995) on Mytilus sp. hemocytes. 
 
4.4 PAHs cytotoxicity 
4.4.1 Naphthalene cytotoxicity 
By definition the EC50 is „„ the time-period over which 50% of the maximum effect is measured 
should be stated explicitly‟‟(Mouton et al., 2002). The EC50 values after 24 hr incubation were 
lower than those after 48 hr for metabolic activity, membrane integrity and glutathione content. 
A possible mechanism for naphthalene was reported previously on a rainbow trout study in 
which the cells exposed to concentrations up to 7.8×10
-4
 mg/L naphthalene (Schirmer et al., 
1998). The EC50 values obtained from the latter study were; (4.21×10
-4 
mg/L) for AB and 
(4.29×10
-4
 mg/L) for CFDA-AM immediately after exposure. After 24 hr lower EC50 
concentration was observed. The EC50 was (3.9×10
-4
 mg/L) for AB and (3.8×10
-4
 mg/L) for 
CFDA-AM. It was concluded that the decrease was affected by perturbation of cell membrane in 
both terms of viability (metabolic activity and membrane integrity). On the contrary of the latter 
study, this study showed lower effect on the membrane integrity compared to the metabolic 
activity and this was determined from the EC50 values (Table 1). A possible explanation for the 
lower effect could be the alternations in membrane properties (leakage of esterase were 
incomplete). This explanation was suggested by Dayeh et al., (2004) who also found an 
unexpected increase in the CF fluorescence after exposure the cells to Triton X-100. In this 
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study, membrane interrupter might have caused decrease in metabolic activity and GSH content. 
This occurs if the cell contents were dismissed when removing the toxicant-containing medium 
and adding Tris buffer. On the other hand, hormetic effect over 100% in comparison to control 
was observed at the higher metabolic activity concentration (Figure 8-a). This effect could be 
due to hormesis causing stimulatory responses at low doses of chemicals (Calabrese, 1999). 
An alternative explanation for the decreased cell viability could be impairment of the 
mitochondria by the cytotoxic effects of naphthalene. By using isolated avian and mammalian 
mitochondria, Harmon and Sanbor (1982) observed inhibition of the mitochondrial respiration 
due to the cytotoxic effect of naphthalene. In this study, a decrease in metabolic activity might 
make it difficult for the cell to maintain its normal activity, with the consequence of a decrease in 
membrane stability and GSH level.  
Another potential reason for decreased viability may be related to the findings of a study 
on Sprague-Dawley rats exposed to naphthalene. In that study, Vuchetich et al. (1996) proposed 
that the toxicity of naphthalene was due to its metabolic conversion to metabolites that resulted a 
in cell damage and glutathione depletion. However, the hypothesis regarding the naphthalene 
biotransformation would be less relevant in relation to this study. Invertebrates generally have a 
lower metabolic capacity than vertebrates, and blue mussels particularly have a low ability to 
metabolize PAHs (Hylland, 2006). Therefore, naphthalene cytotoxicity might be due its 
lipophilic nature. More specifically, it has an ability to integrate into the biological membranes 
and cause impairment effects (Vijayavel and Balasubramanian, 2006). 
4.4.2 Phenanthrene cytotoxicity  
The cell viability data showed that phenanthrene caused a dose dependent cytotoxicity after a 24 
hr and 48 hr exposure. The decrease in viability was observed in terms of metabolic activity, 
membrane integrity, and glutathione content. The 48 hr EC50 values were lower than those of 24 
hr (Table 1). The 24 hr EC50 values for metabolic activity and membrane integrity were 
comparable. A similar results from the two time points (2 hr and 24 hr) was observed by 
Schirmer et al. (1998) on a rainbow trout fish. The EC50 was found to be (9.9×10
-4 
mg/L) after 
24 hr exposure to phenanthrene. It was proposed that the cytotoxic effect was due cell membrane 
damage. Similarly, Hannam et al. (2010) noted that scallops (Pecten maximus) exposed to 
phenanthrene different concentrations (5×10
-2
, 1×10
-2 
, and 2×10
-2 
mg/L) resulted in significant 
reductions in cell membrane stability. In this study, the highest phenanthrene concentration used 
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was 0.04 mg/L, which is similar to the latter study. On the contrary, at the same concentrations 
of the latter study, no significant change in percentage of hemocytes containing non-specific 
esterase activity (interpreted as membrane stability) was observed on M. edulis (Wootton et al., 
2003).  
Another possible mode of phenanthrene action was proposed by Grundy et al. (1996). He 
argued that phenanthrene impairs the lysosomal membrane integrity and immune function of M. 
edulis hemocytes, resulting in the leakage of enzymes. In this study, the consequences of the 
aforementioned effect might be a more general response that includes a loss of integrity of the 
cell membrane. 
There is evidence that PAHs induced effects on the cytochrome P450 in molluscs (Moore 
et al., 1987). However, for this reason, because invertebrates have a rate-limiting cytochrome 
P450 (Livingstone, 1998) and due to the lipophilic properties of phenanthrene. It is more 
reasonable that phenanthrene penetrate the lipid bilayer and cause impairment of cell membrane 
(Grundy et al., 1996). In this study a similar EC50 values for the fluorescent assays were 
obsreved. Therefore a possibility of membrane damage and consequence decrease in metabolic 
activity and GSH content could be considered. 
4.4.3 2,6-Dimethylnaphthalene and 1,5-/1,7-dimethylphenanthrene 
cytotoxicity 
Assessing the cytotoxicity of alkyl PAHs provides more information about structure-toxicity 
relationships. In this study, the degree of cell viability reduction after exposing the hemocytes to 
2,6-dimethylnaphtalene and 1,5-/1,7-dimethylphenanthrene appeared to be dose-responsive.  
As mentioned previously, the general mechanism behind the cytotoxicity of naphthalene 
and phenanthrene appeared to be membrane impairment. In case of alkylated naphthalene and 
phenanthrene the toxic effect would probably be related to the presence of alkyl chain. In 
general, acute toxicity rises with increased alkyl carbon chain length (Dyer et al., 2000). 
Increased alkyl substitution increases lipophilicity (Liu and Sylvester, 1994), strengths the 
impairment effect (Schultz and Cajina-Quezada, 1982) and thereby increases the toxicity of the 
compound tested. For instance, methyl isopropyl phenanthrene is almost ten times more toxic 
than phenanthrene (Turcotte et al., 2011). However in this study, the EC50 values of alkylated 
compounds were found to be almost similar to those of the non-alkylated. A feasible explanation 
for these results might be that the hemocytes exposed to the alkylated PAHs have higher 
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membrane stability than those exposed to the non-alkylated PAHs. The high membrane stability 
may be due to the elevated levels of vitamin E (Lucy, 1972). 
Another possible mechanism was reported in metabolic study of 1,6-dimethylnaphthalene 
in rats. Kilanowicz et al. (2002) suggested that the bioactivation of GSH S-conjugates was a 
possibility by which GSH will be associated with toxicity. However, since vertebrates have 
higher biotransformation capacity than invertebrates, this hypothesis is less supported 
(Livingstone, 1998).  
4.4.4 Pyrene cytotoxicity 
The data shows that pyrene caused a dose dependent cytotoxicity. The 24 hr EC50 were higher 
than those of 48 hr. This indicates that the long exposure period caused more cytotoxic effect. A 
possible mechanism for pyrene may explain from its properties as one of the highly lipophilic 
compounds (Ng et al., 1992). In general, cytotoxicity increased with increasing hydrophobicity 
(Van der Meer et al., 1991). Therefore, a possible mechanism for pyrene might be the highly 
penetration and the consequence effect of compromising the cell membrane. In this study, 
comparable EC50 values after 24 hr was observed from the metabolic activity and membrane 
integrity (Table 1). The loss of viability may be due to the disruption of mitochondrial and cell 
membrane integrity because of the high lipophilicity of pyrene. On the other hand, after 48 hr 
there was more decrease in the metabolic activity compared to the other viability assays at this 
time point (Table 1). A possibility for such decrease might be that the cytotoxic effect of pyrene 
on metabolic activity occurred before any alternations in membrane integrity. Therefore any 
decrease in the viability from the other two assays was a consequence of metabolic activity 
impairment. Another explanation might be that the hemocytes undergo apoptosis. Apoptosis in 
hemocytes are suggested due to inhibition of ATPase and/or mitochondrial ADP/ATP or 
substrate transport (Sokolova et al., 2004). 
On the contrary, no decrease in the non-specific esterase activity in oyster hemocytes was 
observed after exposure to pyrene (200 μmol/L) (Gagnaire et al., 2006). Pyrene was not 
consistently toxic to M. edulis in vivo, but showed complicated behavior depending on 
temperature and salinity (Okay et al., 2006). In sum, a possible mode of action for pyrene may 
be general impairment of cell membrane or still might be due to the biotransformation role in 
toxicity. 
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4.4.5 Benzo(a)pyrene cytotoxicity 
The results indicate that hemocytes exposure to benzo(a)pyrene (BaP) reduced the cell viability 
in a dose responsive manner. The EC50 values calculated at each time point were similar, with 
higher EC50 values of the 24 hr exposure than 48 hr. This might indicate that the decrease in 
viability was due to one of the mechanisms mentioned below. 
For BaP, another mode of toxicity could be proposed than previously suggested. Unlike 
naphthalene, BaP was suggested to be metabolized by M. edulis (Livingstone et al., 1990). The 
antioxidant defense (glutathione) depletion could indicate enhanced ROS production caused by 
the metabolization of BaP in mussels (Livingstone et al., 1990), with a subsequent deleterious 
effect of the ROS on the cell as general. Similarly, Gómez-Mendikute et al. (2002) reported 
deleterious effects on the immune system of Mytilus sp., which he suggests is due to the 
increased production of superoxide anion during BaP metabolism. Another study on the arctic 
scallop, observed depletion in total oxyradical scavenging capacity, this indicates an antioxidant 
defense (glutathione) and impairment of cell membrane stability, after exposure to BaP (0.0, 
74.0, and 90.6 mg/L). The former had higher concentrations than this study due to difference in 
exposures and durations in the producers. It was also suggested that the depletion in antioxidant 
defense was due to ROS production, enhanced by the metabolization of BaP (Camus et al., 
2002).  
Another explanation for the low cell viability could be that the mitochondria was the 
cellular target for BaP, with quinine-induced cytotoxicity, thus resulting in direct disruption of 
energy metabolism (Miller and Ramos, 2001). Therefore this led to the reduction in the cell 
viability observed from the other assays. 
A third explanation could be that BaP evoked its toxicity by binding on lipophilic 
molecules, thus compromising the basic functions of cells (Camus et al., 2002). The 24 hrs EC50 
values were similar when measuring the metabolic activity and the integrity of cell. At the 
second time point lower, EC50 values were observed with comparable values of the fluorescent 
indicator dyes (Table 1). Thus, this might indicate a toxic mechanism with consequence cell 
damage. 
In sum, although organic xenobiotics such as PAHs have greater potential for 
biotransformation in fish compared with the aquatic invertebrates (Livingstone, 1998), one could 
still conclude that the toxicity of BaP might be caused by either; metabolic formation of toxic 
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metabolites due to biotransformation ; or through the impairment of the cell membranes due to 
the high lipophilicity of BaP. 
 
4.5 Comparison between PAHs cytotoxicity 
The EC50 of the dose response curve represented the concentration of the PAHs where 50% of 
the concentration showed a response. A lower EC50 indicates higher toxicity. The EC50 values 
from the three cytotoxicity assays were used to rank these compounds. BaP and pyrene were 
found to be the most toxic, judged by their lower EC50 at each time point. The EC50 values 
(g/mol) at the first time point (24 hr) were: 2.47×10
-7
, 3.90×10
-8
 (AB), 2.47×10
-7
, 4.98×10
-8
 
(CFDA-AM), and not computed (mBCI). At the second time point (48 hr): 9.80×10
-16
, 1.90×10
-9
 
(AB), 3.11×10
-9
, not computed (CFDA-AM), and 7.8×10
-9
, 7.9×10
-10
 (mBCI) of pyrene and Bap, 
respectively. 
As mentioned previously, BaP might evoke its toxicity by biotransformation and formation 
of ROS, and through other modes of action. BaP and pyrene have a log octanol-water partition 
coefficient (log Kow) of 6.04 and 5.18, respectively, which is higher than the log Kow of 
naphthalene and phenanthrene (3.33 and 4.57), respectively (Hylland, 2006). Hence, it is 
expected that naphthalene and phenanthrene have less toxic effect. Naphthalene and 
phenanthrene EC50 values were higher than pyrene and BaP. The EC50 values (g/mol) at the first 
time point were: 6.19×10
-7
, 3.50×10
-6
 (AB), 7.7×10
-3
, 4.45×10
-6
 (CFDA-AM), and 2.46×10
-5
, 
5.60×10
-8
 (mBCI). At the second time point: 1.56×10
-7
, not computed (AB), 1.23×10
-5
, 1.11×10
-7
 
(CFDA-AM), and not computed, 1.40×10
-8
 (mBCI) of naphthalene and phenanthrene, 
respectively. 
2,6-Dimethylnaphtalene and 1,5-/1,7-dimethylphenanthrene EC50 values were similar or 
slightly lower than the non-alkylated, which as proposed was to their higher membrane stability. 
The EC50 values (g/mol) at the first time point: 2.02×10
-4 
, 6.40×10
-6
 (AB), 2.02×10
-4
, 1.27×10
-5
 
(CFDA-AM), and 2.02×10
-4
, 6.40×10
-5
 (mBCI). At the second time point were: 2.54×10
-7
, 
1.60×10
-7
 (AB), 4.03×10
-7
 , not computed (CFDA-AM), and 2.02×10
-4
 , 1.01×10
-5
 (mBCI) of 
2,6-dimethylnaphthalene and 1,5-/1,7-dimethylphenanthrene, respectively. 
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5 Conclusions 
A cell density of 200 000 cells per mL proved to be the appropriate density. L-15(+) was found 
to be the most appropriate medium of choice to maintain the viability of hemocytes and to 
provide aseptic conditions. 0.2% DMSO concentration is the least toxic choice to the hemocytes. 
This study demonstrated that M.edulis hemocytes exposed to the selected PAHs 
(naphthalene, phenanthrene, pyrene, benzo(a)pyrene, 2,6-dimethylnaphtalene, 1,5-/1,7-dimethyl-
phenantrene) had decreased the cell viability in terms of metabolic activity, membrane integrity 
and glutathione content. A dose-dependent decrease was observed in hemocytes after exposure 
to each compound. The EC50 values determined for the tested PAHs indicated a general tendency 
of increasing toxicity with the exposure periods (24 hr and 48 hr). 
Different mechanisms were proposed for each PAH. The lipophilic character of 
naphthalene appears to be the reason for its toxic action. This was by perturbation of cell 
membrane or through a specific action on mitochondria. An increased 24 hr EC50 value for 
membrane integrity was observed, which might be due alternations in membrane properties. 
Phenanthrene might evoke its toxicity with the similar mode of action as naphthalene but with 
more cytotoxic effect. For the substituted PAHs, the EC50 values were similar or slightly lower 
than the non-alkylated PAHs, which might be due to the higher membrane stability of hemocytes 
exposed to the alkylated PAHs. The increased toxicity of pyrene than the other PAHs might be 
linked to its high lipophilicity (log Kow 5.18). The EC50 values of the assays measured were close 
at each time point, but with more decrease of the 48 hr EC50 value for metabolic activity. This 
might be due to apoptosis or pyrene effect on the metabolic activity. BaP may express its toxicity 
by metabolism and biotransformation or due its high lipophilicity. The two time points EC50 
values obtained from the three assays were similar. In conclusion, this study shows the 
possibility that hemocytes can be successfully used as biomarkers with cell viability as 
endpoints. 
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5.1 Future perspectives 
a) Comparative investigation into the effects of polycyclic aromatic hydrocarbon on the 
mussel hemocytes and other sensitive cells should be assessed. This may help to obtain 
insight into the variations in sensitivity and understand more about the mechanisms of 
PAHs-induced cell injury. 
b) Marine invertebrate hemocytes under in vitro conditions are important tools in a variety 
of scientific disciplines. However, the establishment of cell cultures has been encountered 
with obstacles. Hence, there are considerable requirements for further testing of protocols 
with respect to cell culture improvements. 
c) Scientists often need to count cells prior to cell culture with an accurate number of input 
cells. An automated cell counter is needed to obtain an accurate cell counts and to 
accelerate the cell work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
 
6  Reference list 
 
Ahmed, S. A., Gogal, R. M., Jr. and Walsh, J. E. (1994). "A new rapid and simple non-radioactive assay to monitor 
and determine the proliferation of lymphocytes: an alternative to [
3
H]thymidine incorporation assay." 
Journal of Immunological Methods 170: 211-224. 
Al-Subiai, S., Jha, A. and Moody, A. (2009). "Contamination of bivalve haemolymph samples by adductor muscle 
components: implications for biomarker studies." Ecotoxicology 18: 334-342. 
Arala-Chaves, M. and Sequeira, T. (2000). "Is there any kind of adaptive immunity in invertebrates?" Aquaculture 
191: 247-258. 
Auffret, M. and Oubella, R. (1997). "Hemocyte aggregation in the oyster Crassostrea gigas: In vitro measurement 
and experimental modulation by xenobiotics." Comparative Biochemistry and Physiology Part A: 
Physiology 118: 705-712. 
Bell, C. C., Finger, T. E. and Russell, C. J. (1981). "Central connections of the posterior lateral line lobe in mormyrid 
fish." Experimental Brain Research 42: 9-22. 
Bocquené, G., Chantereau, S., Clérendeau, C., Beausir, E., Ménard, D., Raffin, B., Minier, C., Burgeot, T., Leszkowicz, 
A. P. and Narbonne, J.-F. (2004). "Biological effects of the “Erika” oil spill on the common mussel (Mytilus 
edulis)." Aquatic Living Resources 17: 309-316. 
Brown, J. R., Field, R. A., Goldstone, M. E., Lester, J. N. and Perry, R. (1996). "Polycyclic aromatic hydrocarbons in 
central London air during 1991 and 1992." Science of The Total Environment 177: 73-84. 
Calabrese, E. J. (1999). "Evidence that hormesis represents an "overcompensation" response to a disruption in 
homeostasis." Ecotoxicology and Environmental Safety 42: 135-137. 
Camus, L., Jones, M. B., Børseth, J. F., Grøsvik, B. E., Regoli, F. and Depledge, M. H. (2002). "Total oxyradical 
scavenging capacity and cell membrane stability of haemocytes of the Arctic scallop, Chlamys islandicus, 
following benzo(a)pyrene exposure." Marine Environmental Research 54: 425-430. 
Cao, A., Mercado, L., Ramos-Martinez, J. I. and Barcia, R. (2003). "Primary cultures of hemocytes from Mytilus 
galloprovincialis Lmk.: expression of IL-2Rα subunit." Aquaculture 216: 1-8. 
Chase, M. E., Jones, S. H., Hennigar, P., Sowles, J., Harding, G. C., Freeman, K., Wells, P. G., Krahforst, C., Coombs, 
K., Crawford, R., Pederson, J. and Taylor, D. (2001). "Gulfwatch: monitoring spatial and temporal patterns 
of trace metal and organic contaminants in the Gulf of Maine (1991-1997) with the blue mussel, Mytilus 
edulis L." Marine Pollution Bulletin 42: 491-505. 
Chen, J. H. and Bayne, C. J. (1995). "Bivalve mollusc hemocyte behaviors: characterization of hemocyte aggregation 
and adhesion and their inhibition in the california mussel (Mytilus californianus)." Biological Bulletin 188: 
255-266. 
Coles, J. A., Farley, S. R. and Pipe, R. K. (1995). "Alteration of the immune response of the common marine mussel 
Mytilus edulis resulting from exposure to cadmium." Diseases of Aquatic Organisms  22: 59-65. 
Coray, C., St.-Jean, S. D. and Bard, S. M. (2007). "Immunomodulation in blue mussels (Mytilus edulis and Mytilus 
trossulus) exposed to municipal effluent in eastern Canada." The Water Quality Research Journal of 
Canada 42: 194-201. 
Dayeh, V. R., Chow, S. L., Schirmer, K., Lynn, D. H. and Bols, N. C. (2004). "Evaluating the toxicity of Triton X-100 to 
protozoan, fish, and mammalian cells using fluorescent dyes as indicators of cell viability." Ecotoxicology 
and Environmental Safety 57: 375-382. 
Devlin, R. B., Frampton, M. L. and Ghio, A. J. (2005). "In vitro studies: What is their role in toxicology?" 
Experimental and Toxicologic Pathology 57: 183-188. 
Dyer, S. D., Stanton, D. T., Lauth, J. R. and Cherry, D. S. (2000). "Structure–activity relationships for acute and 
chronic toxicity of alcohol ether sulfates." Environmental Toxicology and Chemistry 19: 608-616. 
Ellesat, K. S., Tollefsen, K.-E., Asberg, A., Thomas, K. V. and Hylland, K. (2010). "Cytotoxicity of atorvastatin and 
simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes." Toxicology in Vitro 24: 1610-
1618. 
 
 
44 
 
Engraff, M., Solere, C., Smith, K. E. C., Mayer, P. and Dahllöf, I. (2011). "Aquatic toxicity of PAHs and PAH mixtures 
at saturation to benthic amphipods: Linking toxic effects to chemical activity." Aquatic Toxicology 102: 
142-149. 
Esteban-Pretel, G. and Pilar López-García, M. (2006). "An experimental design for the controlled modulation of 
intracellular GSH levels in cultured hepatocytes." Free Radical Biology and Medicine 41: 610-619. 
Fernández-Checa, J. and Kaplowitz, N. (1990). "The use of monochlorobimane to determine hepatic GSH levels and 
synthesis." Analytical Biochemistry 190: 212-219. 
Gagnaire, B., Thomas-Guyon, H., Burgeot, T. and Renault, T. (2006). "Pollutant effects on Pacific oyster, Crassostrea 
gigas (Thunberg), hemocytes: Screening of 23 molecules using flow cytometry." Cell Biology and 
Toxicology 22: 1-14. 
Gómez-Mendikute, A., Etxeberria, A., Olabarrieta, I. and Cajaraville, M. P. (2002). "Oxygen radicals production and 
actin filament disruption in bivalve haemocytes treated with benzo(a)pyrene." Marine Environmental 
Research 54: 431-436. 
Grundy, M. M., Moore, M. N., Howell, S. M. and Ratcliffe, N. A. (1996). "Phagocytic reduction and effects on 
lysosomal membranes by polycyclic aromatic hydrocarbons, in haemocytes of Mytilus edulis." Aquatic 
Toxicology 34: 273-290. 
Gustafson, L. L., Stoskopf, M. K., Bogan, A. E., Showers, W., Kwak, T. J., Hanlon, S. and Levine, J. F. (2005). 
"Evaluation of a nonlethal technique for hemolymph collection in Elliptio complanata, a freshwater 
bivalve (Mollusca: Unionidae)." Diseases of Aquatic Organisms 65: 159-165. 
Hannam, M. L., Bamber, S. D., Galloway, T. S., John Moody, A. and Jones, M. B. (2010). "Effects of the model PAH 
phenanthrene on immune function and oxidative stress in the haemolymph of the temperate scallop 
Pecten maximus." Chemosphere 78: 779-784. 
Harmon, H. J. and Sanborn, M. R. (1982). "Effect of naphthalene on respiration in heart mitochondria and intact 
cultured cells." Environmental Research 29: 160-173. 
Hartl, M. G. J., Grigson, S. J. W. and Sinet, E. (2010). "Maintenance of bivalve hemocytes for the purpose of delayed 
DNA strand break assessment using the comet assay." Environmental and Molecular Mutagenesis 51: 64-
68. 
Hylland, K. (2006). "Polycyclic aromatic hydrocarbon (PAH) ecotoxicology in marine ecosystems." Journal of 
Toxicology and Environmental Health 69: 109-123. 
Kammann, U., Bunke, M., Steinhart, H. and Theobald, N. (2001). "A permanent fish cell line (EPC) for genotoxicity 
testing of marine sediments with the comet assay." Mutation Research/Genetic Toxicology and 
Environmental Mutagenesis 498: 67-77. 
Kilanowicz, A., Sapota, A. and Czerski, B. (2002). "Disposition and metabolism of 1,6-dimethylnaphthalene in rats." 
Toxicology Letters 134: 227-235. 
Kontir, D. M., Glance, C. A., Colby, H. D. and Miles, P. R. (1986). "Effects of organic solvent vehicles on 
benzo[a]pyrene metabolism in rabbit lung microsomes." Biochemical Pharmacology 35: 2569-2575. 
Koyama, J. and Kakuno, A. (2004). "Toxicity of heavy fuel oil, dispersant, and oil-dispersant mixtures to a marine 
fish, Pagrus major." Fisheries Science 70: 587-594. 
Leibovitz, A. (1963). "The growth and maintenance of tissue-cell cultures in free gas exchange with the 
atmosphere." American Journal of Epidemiology 78: 173-180. 
Li, C. and Shields, J. D. (2007). "Primary culture of hemocytes from the Caribbean spiny lobster, Panulirus argus, 
and their susceptibility to Panulirus argus Virus 1 (PaV1)." Journal of Invertebrate Pathology 94: 48-55. 
Liu, S.-Y. and Sylvester, D. M. (1994). "Antiplatelet structure-activity relationship of tetramethylpyrazine." Life 
Sciences 55: 1317-1326. 
Livingstone, D. R. (1998). "The fate of organic xenobiotics in aquatic ecosystems: quantitative and qualitative 
differences in biotransformation by invertebrates and fish." Comparative Biochemistry and Physiology - 
Part A: Molecular and Integrative Physiology 120: 43-49. 
Livingstone, D. R., Martinez, P. G., Michel, X., Narbonne, J. F., O'Hara, S., Ribera, D. and Winston, G. W. (1990). 
"Oxyradical production as a pollution-mediated mechanism of toxicity in the common mussel, Mytilus 
edulis L., and other molluscs." Functional Ecology 4: 415-424. 
Lucy, J. A. (1972). "Functional and structural aspects of biological membranes: A suggested structural role for 
vitamin E in the control of membrane permeability and stability." Annals of the New York Academy of 
Sciences 203: 4-11. 
 
 
45 
 
Magi, E., Bianco, R., Ianni, C. and Di Carro, M. (2002). "Distribution of polycyclic aromatic hydrocarbons in the 
sediments of the Adriatic Sea." Environmental Pollution 119: 91-98. 
Manoli, E. and Samara, C. (1999). "Polycyclic aromatic hydrocarbons in natural waters: sources, occurrence and 
analysis." Trends in Analytical Chemistry 18: 417-428. 
Miller, K. P. and Ramos, K. S. (2001). "Impact of cellular metabolism on the biological effects of benzo[a]pyrene 
and related hydrocarbons." Drug Metabolism Reviews 33: 1-35. 
Montejano, H. A., Gervaldo, M. and Bertolotti, S. G. (2005). "The excited-states quenching of resazurin and 
resorufin by p-benzoquinones in polar solvents." Dyes and Pigments 64: 117-124. 
Moore, M. N., Livingstone, D. R., Widdows, J., Lowe, D. M., Pipe, R. K. and Jones, R. E. (1987). "Molecular, cellular 
and physiological effects of oil-derived hydrocarbons on molluscs and their use in impact assessment " 
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 316: 603-623. 
Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H. and Drusano, G. L. (2002). "Standardization of 
pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs." International Journal of 
Antimicrobial Agents 19: 355-358. 
Nakayama, G. R., Caton, M. C., Nova, M. P. and Parandoosh, Z. (1997). "Assessment of the Alamar Blue assay for 
cellular growth and viability in vitro." Journal of Immunological Methods 204: 205-208. 
Ng, K. M. E., Chu, I., Bronaugh, R. L., Franklin, C. A. and Somers, D. A. (1992). "Percutaneous absorption and 
metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl) phthalate: Comparison of in vitro and in vivo 
results in the hairless guinea pig." Toxicology and Applied Pharmacology 115: 216-223. 
Okay, O. S., Tolun, L., Tüfekçi, V., Telli-Karakoç, F. and Donkin, P. (2006). "Effects of pyrene on mussels in different 
experimental conditions." Environment International 32: 538-544. 
Pappenheimer, A. M. (1917). "Experimental studies upon lymphocytes: the reactions of lymphocytes under various 
experimental conditions." The Journal of Experimental Medicine 25: 633-650. 
Qi, W., Ding, D. and Salvi, R. J. (2008). "Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic 
cultures." Hearing Research 236: 52-60. 
Quinn, B., Costello, M., Dorange, G., Wilson, J. and Mothersill, C. (2009). "Development of an in vitro culture 
method for cells and tissues from the zebra mussel (Dreissena polymorpha)." Cytotechnology 59: 121-134. 
Reiber, C. L. and McGaw, I. J. (2009). "A Review of the “open” and “closed” circulatory systems: new terminology 
for complex invertebrate circulatory systems in light of current findings." International Journal of Zoology 
2009: 1-8. 
Rinkevich, B. (1999). "Cell cultures from marine invertebrates: obstacles, new approaches and recent 
improvements." Journal of Biotechnology 70: 133-153. 
Saeed, T. and Al-Mutairi, M. (2000). "Comparative composition of polycyclic aromatic hydrocarbons (PAHs) in the 
sea water-soluble fractions of different Kuwaiti crude oils." Advances in Environmental Research 4: 141-
145. 
Saha, M., Togo, A., Mizukawa, K., Murakami, M., Takada, H., Zakaria, M. P., Chiem, N. H., Tuyen, B. C., Prudente, 
M., Boonyatumanond, R., Sarkar, S. K., Bhattacharya, B., Mishra, P. and Tana, T. S. (2009). "Sources of 
sedimentary PAHs in tropical Asian waters: Differentiation between pyrogenic and petrogenic sources by 
alkyl homolog abundance." Marine Pollution Bulletin 58: 189-200. 
Schirmer, K., Chan, A. G. J., Greenberg, B. M., Dixon, D. G. and Bols, N. C. (1997). "Methodology for demonstrating 
and measuring the photocytotoxicity of fluoranthene to fish cells in culture." Toxicology in Vitro 11: 107-
113. 
Schirmer, K., Chan, A. G. J., Greenberg, B. M., Dixon, D. G. and Bols, N. C. (1998). "Ability of 16 priority PAHs to be 
photocytotoxic to a cell line from the rainbow trout gill." Toxicology 127: 143-155. 
Schreer, A., Tinson, C., Sherry, J. P. and Schirmer, K. (2005). "Application of Alamar blue/5-carboxyfluorescein 
diacetate acetoxymethyl ester as a noninvasive cell viability assay in primary hepatocytes from rainbow 
trout." Analytical Biochemistry 344: 76-85. 
Schultz, T. W. and Cajina-Quezada, M. (1982). "Structure-toxicity relationships of selected nitrogenous heterocyclic 
compounds II. Dinitrogen molecules." Archives of Environmental Contamination and Toxicology 11: 353-
361. 
Shahan, T. A., Siegel, P. D., Sorenson, W. G., Kuschner, W. G. and Lewis, D. M. (1994). "A sensitive new bioassay for 
tumor necrosis factor." Journal of Immunological Methods 175: 181-187. 
 
 
46 
 
Sokolova, I. M., Evans, S. and Hughes, F. M. (2004). "Cadmium-induced apoptosis in oyster hemocytes involves 
disturbance of cellular energy balance but no mitochondrial permeability transition." The Journal of 
Experimental Biology 207: 3369-3380. 
Spink, D. C., Wu, S. J., Spink, B. C., Hussain, M. M., Vakharia, D. D., Pentecost, B. T. and Kaminsky, L. S. (2008). 
"Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast 
cancer cells: Roles of PAH interactions and PAH metabolites." Toxicology and Applied Pharmacology 226: 
213-224. 
Turcotte, D., Akhtar, P., Bowerman, M., Kiparissis, Y., Brown, R. S. and Hodson, P. V. (2011). "Measuring the toxicity 
of alkyl-phenanthrenes to early life stages of medaka (Oryzias latipes) using partition-controlled delivery." 
Environmental Toxicology and Chemistry 30: 487-495. 
Van der Meer, R., Termont, D. S. and De Vries, H. T. (1991). "Differential effects of calcium ions and calcium 
phosphate on cytotoxicity of bile acids." The American Journal of Physiology 260: G142-147. 
Vijayavel, K. and Balasubramanian, M. P. (2006). "Changes in oxygen consumption and respiratory enzymes as 
stress indicators in an estuarine edible crab Scylla serrata exposed to naphthalene." Chemosphere 63: 
1523-1531. 
Vuchetich, P. J., Bagchi, D., Bagchi, M., Hassoun, E. A., Tang, L. and Stohs, S. J. (1996). "Naphthalene-induced 
oxidative stress in rats and the protective effects of vitamin E succinate." Free Radical Biology and 
Medicine 21: 577-590. 
Wenli, C. and Shields, J. D. (2007). "Characterization and primary culture of hemocytes from the blue crab , 
Callinectes sapidus." Transactions of the Chinese Crustacean Society 5: 25-35. 
Wootton, E. C., Dyrynda, E. A., Pipe, R. K. and Ratcliffe, N. A. (2003). "Comparisons of PAH-induced 
immunomodulation in three bivalve molluscs." Aquatic Toxicology 65: 13-25. 
Yu, Z. W. and Quinn, P. J. (1994). "Dimethyl sulphoxide: A review of its applications in cell biology." Bioscience 
Reports 14: 259-281. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
7 Appendix 
7.1 Appendix A: Chemicals and equipments  
 
Beckman CoulterTM  
MultisizerTM 3, Coulter counter®  
 
BioSource Europe S.A., Nivelles, Belgium  
 
Biowhittaker Inc., Walkerswille, Maryland, USA  
Leibowitz (L-15) medium 
 
Cambrex East Rutherford, NJ, USA 
Pencicillin 
Streptomycin  
Amphotenzin 
 
Chiron AS,Trondheim, Norway and Sigma-Aldrich, St. Louis, MO 
Polycyclic aromatic hydrocarbons compounds 
 
Merck, Whitehouse Station, New Jersey, USA  
Monopotassium phosphate (KH2PO4) 
Sodium chloride (NaCl) 
Sodium Hydroxide (NaOH) 
 
Molecular Probes, Paisley, United Kingdom 
Alamar BlueTM (AB) 
5-Carboxyfluorescein diacetate, actetoxymethyl ester (CFDA-AM) 
Monochlorobimane (mBCl) 
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Sigma–Aldrich Norway AS, Oslo, Norway 
Ethylene diamine tetraacetic acid (EDTA) 
Royal Park Memorial Institute (RPMI) 
Disodium hydrogen phosphate (Na2HPO4)  
Trypan blue 
Dimethyl sulfoxide (DMSO) 
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7.2 Appendix B: Raw data 
 
Media optimization -data
AB-24 hr AB-48 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
1439 987 814 994 1592 904 740 871
1263 1009 818 771 1402 900 733 730
1314 985 769 758 1522 902 747 718
1435 1148 1059 779 1627 1003 941 710
956 769 725 949 880 676 691 817
756 744 776 729 757 710 705 751
738 700 752 706 746 703 708 714
717 941 961 729 758 820 868 726
993 733 731 917 896 666 646 890
697 754 748 689 757 684 576 739
743 734 710 720 720 682 686 674
724 969 906 714 715 858 843 699
993 712 721 931 847 636 685 877
697 736 763 683 712 621 674 695
743 732 751 726 682 676 710 727
724 949 918 723 676 790 895 683
938 698 750 838 1075 678 680 777
723 737 706 716 915 676 700 713
778 734 741 725 937 678 704 691
772 807 889 720 954 783 809 684
AB-96 hr AB-192 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
479 308 388 310 195 167 19 62
604 294 353 241 105 158 130 41
490 326 380 222 127 58 146 24
405 376 218 209 115 158 171 61
448 232 261 261 144 75 82 72
491 233 255 11 66 14 125 23
674 224 266 16 101 28 190 16
748 298 385 24 144 60 131 62
540 230 293 311 165 60 145 142
460 223 283 234 32 13 99 41
602 237 257 220 72 48 23 50
547 328 370 239 147 61 59 24
451 233 306 297 40 71 161 25
410 231 285 241 85 59 188 99
534 217 319 226 73 27 100 29
575 320 440 234 97 71 131 30
441 236 246 279 108 64 91 19
498 214 250 230 124 61 81 129
679 231 275 224 10 3 79 130
480 288 326 226 13 59 71 50
CFDA-AM-24 hr CFDA-AM-48 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
228 297 162 213 204 90 137 131
187 240 190 136 215 139 98 105
191 244 140 160 172 113 102 174
220 397 263 155 188 136 152 118
131 118 151 182 141 53 52 47
72 70 152 113 103 57 45 8
108 64 130 115 97 77 45 7
70 91 211 126 95 113 72 7
148 67 95 92 153 55 72 57
75 100 142 83 108 54 70 49
83 75 112 125 89 60 78 52
73 127 200 127 107 74 114 54
180 161 110 209 176 89 95 101
87 159 180 115 145 88 82 75
158 187 146 123 171 91 94 75
165 277 230 84 129 135 149 83
241 192 240 250 136 84 116 132
141 344 103 196 141 81 118 102
162 306 234 183 133 120 120 91
200 346 279 171 122 144 174 113
CFDA-AM-96 hr CFDA-AM-192 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
181 83 125 118 70 73 54 54
189 127 88 95 60 69 62 35
152 101 94 154 60 67 47 43
166 124 138 105 67 115 88 41
125 47 48 42 35 34 50 46
91 51 40 7 22 23 51 29
88 69 41 7 32 22 45 31
85 101 66 7 23 29 72 34
136 50 66 50 43 22 31 27
96 49 64 43 24 31 48 24
78 53 70 47 26 25 40 32
94 67 104 48 24 39 68 30
157 79 85 90 51 46 36 49
130 79 74 67 27 47 52 29
156 82 85 67 45 55 48 31
113 121 134 73 48 80 73 25
123 75 106 119 66 57 77 59
124 72 107 92 40 86 41 51
117 108 108 79 41 88 80 49
108 130 159 101 55 105 91 48
mBCI-24 hr mBCI-48 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
37 39 35 35 42 42 37 38
35 39 34 32 41 42 37 37
38 39 33 32 43 41 37 37
37 38 37 31 43 42 41 37
32 36 34 34 36 38 37 35
32 33 35 35 38 38 38 37
34 34 36 34 37 37 38 37
34 34 36 34 38 40 38 38
33 34 34 31 51 38 35 38
33 37 35 31 37 38 30 37
33 36 34 35 38 39 39 39
32 37 38 33 38 39 35 39
34 36 36 33 40 36 36 40
33 34 39 33 38 34 38 36
55 35 37 33 39 36 38 38
34 38 37 33 39 45 39 39
31 34 34 31 37 37 37 36
33 35 33 32 38 38 38 35
33 35 35 33 59 39 38 37
33 37 35 31 40 38 36 37
mBCI-96 hr mBCI-192 hr
L-15 L-15(+) RPMI PBS L-15 L-15(+) RPMI PBS
52 36 43 44 120 128 121 92
44 45 46 41 116 124 112 96
43 53 49 50 124 93 120 116
42 50 53 42 121 85 107 96
45 40 38 49 120 93 115 93
41 47 41 39 119 90 120 94
44 46 45 42 112 127 119 95
40 48 48 40 138 125 89 94
50 43 51 48 118 124 122 92
44 46 51 46 120 108 109 112
44 48 51 46 96 113 108 98
46 50 53 49 125 124 122 96
50 53 50 46 92 122 126 91
47 50 51 48 123 101 123 92
46 52 51 46 117 123 124 94
50 53 51 49 130 128 34 95
46 51 51 44 108 124 102 94
48 50 52 46 122 93 98 93
49 48 52 46 111 85 97 95
53 50 49 50 90 93 108 94
DMSO AB
CONTROL 0.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
622,3333 523,25 585,3333 321 398,25 269,3333
608,3 492,25 184,3333 324 156,25 161,3333
267,3 371,25 138,3333 289 284,25 293,3333
643,3 487,25 205,3333 257 216,25 167,3333
333,3 348,25 228,3333 431 334,25 224,3333
320,3 430,25 582,3333 537 122,25 70,33333
383,3 507,25 241,3333 231 318,25 94,33333
275,3 214,25 149,3333 269 303,25 131,3333
286,3 554,25 192,3333 259 261,25 69,33333
414,3 325,25 300,3333 427 195,25 303,3333
721,3 447,25 720,3333 521 109,25 267,3333
458,3 618,25 347,3333 133 476,25 150,3333
437,3 389,25 151,3333 218 463,25 191,3333
295,3 615,25 162,3333 232 165,3333
412,3 449,25 308,3333 352
0.8% 3.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
254 291,25 130,3333 205 212,25 101,3333
97 292,25 152,3333 292 25,33333 57,33333
367 345,25 137,3333 210 67,33333 42,33333
429 401,25 321,3333 107 244,25 47,33333
211 277,25 175,3333 194 362,25 153,3333
184 281,25 89,33333 210 72,33333 138,3333
169 275,25 135,3333 213 62,25 146,3333
423 320,25 150,3333 184 269,25 123,3333
127 297,25 271,3333 56 260,25 239,3333
263 315,25 165,3333 314 113,25 135,3333
261 308,25 81,33333 262 62,25 236,25
260 286,25 125,3333 299 272,25 250,25
311 324,25 235,3333 275 241,25 141,25
381,25 223,25 196,3333
DMSO CFDA-AM
CONTROL 0.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
1205,6 1172,5 1259,9 862,6 1051,5 153,9
1413,6 389,5 1231,9 438,6 1008,5 241,9
1119,6 1252,5 766,9 850,6 441,5 712,9
811,6 992,5 881,9 540,6 445,5 663,9
1432,6 570,5 475,9 521,6 513,5 296,9
810,6 1143,5 345,9 982,6 976,5 281,9
443,6 380,5 328,9 374,6 917,5 132,9
1453,6 1010,5 802,9 687,6 504,5 612,9
627,6 1295,5 507,9 590,6 443,5 779,9
616,6 629,5 480,9 620,6 411,5 329,9
684,6 551,5 466,9 881,6 1162,5 252,9
666,6 446,5 1214,9 448,6 1067,5 596,9
721,6 1279,5 663,9 963,6 602,5 699,9
678,6 996,5 672,9 1000,6 372,5 299,9
757,6 731,5 414,9 431,5
DMSO CFDA-AM
0.8% 3.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
492,6 368,5 337,9 379,6 319,5 234,9
583,6 341,5 329,9 518,6 289,5 76,9
850,6 1102,5 777,9 617,6 248,5 192,9
809,6 880,5 958,9 473,6 413,5 325,9
1323,6 681,5 264,9 410,6 451,5 284,9
1126,6 392,5 253,9 675,6 309,5 358,9
616,6 398,5 162,9 526,6 355,5 89,9
627,6 1003,5 814,9 581,6 443,5 276,9
502,6 1040,5 807,9 507,6 453,5 362,9
711,6 531,5 189,9 461,6 377,5 347,9
973,6 403,5 225,9 414,6 384,5 260,9
487,6 275,5 236,9 496,6 486,5 229,9
724,6 999,5 676,9 503,6 384,5 331,9
874,6 960,5 701,9 489,5 310,9
559,6 466,5 257,9 299,9
DMSO mBCI
CONTROL 0.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
1205,6 1172,5 1259,9 862,6 372,5 153,9
1413,6 389,5 1231,9 438,6 431,5 241,9
1119,6 1252,5 766,9 850,6 1051,5 712,9
811,6 992,5 881,9 540,6 1008,5 663,9
1432,6 570,5 475,9 521,6 441,5 296,9
810,6 1143,5 345,9 982,6 445,5 281,9
443,6 380,5 328,9 374,6 513,5 132,9
1453,6 1010,5 802,9 687,6 976,5 612,9
627,6 1295,5 507,9 590,6 917,5 779,9
616,6 629,5 480,9 620,6 504,5 329,9
684,6 551,5 466,9 881,6 443,5 252,9
666,6 446,5 1214,9 448,6 411,5 596,9
721,6 1279,5 663,9 963,6 1162,5 699,9
678,6 996,5 672,9 1000,6 1067,5 299,9
757,6 731,5 414,9 602,5
0.8% 3.2%
24 hr 48 hr 96 hr 24 hr 48 hr 96 hr
850,6 1102,5 777,9 410,6 319,5 234,9
809,6 880,5 958,9 675,6 289,5 76,9
1323,6 681,5 264,9 526,6 248,5 192,9
1126,6 392,5 253,9 581,6 413,5 325,9
616,6 398,5 162,9 507,6 451,5 284,9
627,6 1003,5 814,9 461,6 309,5 358,9
502,6 1040,5 807,9 414,6 355,5 89,9
711,6 531,5 189,9 496,6 443,5 276,9
973,6 403,5 225,9 503,6 453,5 362,9
487,6 275,5 236,9 379,6 377,5 347,9
492,6 368,5 337,9 518,6 384,5 260,9
583,6 341,5 329,9 617,6 486,5 229,9
724,6 999,5 676,9 473,6 384,5 331,9
874,6 960,5 701,9 489,5 310,9
559,6 466,5 257,9 299,9
PAHs AB-24 hr exposure
Naphthalene Phenanthrene Pyrene
37 33 33 38 40 43 33 38 41
27 28 33 36 44 32 37 42 40
32 40 39 40 37 40 40 42 45
34 33 36 48 49 43 40 45 40
33 35 33 36 38 34 37 43 47
31 31 33 42 39 38 32 42 34
26 38 37 40 38 33 44 45 42
36 20 31 40 31 34 37 35 35
Benzo( a)pyrene 2,6-Dimethylnaphthalene 1,5-/1,7-Dimethylphenanthrene
37 40 41 40 46 36 39 35 47
45 41 43 38 40 39 45 40 27
44 45 43 42 43 41 42 42 35
25 35 33 41 46 41 43 42 31
37 48 41 35 48 46 41 44 48
33 42 34 41 40 33 41 32 39
28 42 36 28 42 36 48 38 44
38 32 39 38 32 39 38 41 39
PAHs AB-48 hr exposure
Naphthalene Phenanthrene Pyrene
43 40 39 34 38 42 37 38 29
37 39 42 30 40 33 34 30 33
38 37 36 32 32 34 39 36 38
35 35 43 38 31 27 35 34 33
36 27 34 33 41 30 45 34 36
40 35 37 36 31 36 36 34 36
39 42 42 28 31 32 32 39 32
41 42 39 34 28 32 30 33 35
Benzo( a)pyrene 2,6-Dimethylnaphthalene 1,5-/1,7-Dimethylphenanthrene
38 48 34 35 34 42 35 42 35
32 44 40 31 41 33 30 48 32
31 38 30 39 35 39 33 34 32
25 35 33 34 38 35 42 27 36
31 30 35 35 37 39 36 39 38
36 31 36 35 38 39 37 36 33
39 35 38 36 44 39 32 35 38
40 37 32 34 36 22 38 39 42
PAHs CFDA-AM-24 hr exposure
Naphthalene Phenanthrene Pyrene
47 43 59 18 22 15 16 17 22
24 33 25 27 10 20 23 28 92
24 35 54 40 37 40 37 44 38
25 63 48 48 49 43 38 45 46
23 17 21 31 38 34 37 38 42
36 34 32 25 28 23 9 15 18
37 39 29 9 14 26 18 26 17
9 20 30 22 29 29 31 12 24
Benzo (a)pyrene 1,5-/1,7-Dimethylphenanthrene 2,6-Dimethylnaphthalene
21 19 21 18 19 29 12 15 27
42 49 43 26 22 19 58 43 45
42 45 40 42 43 35 42 38 41
36 37 40 42 42 40 41 36 41
37 34 40 35 31 48 35 38 43
12 13 18 16 23 16 14 15 19
20 25 26 21 20 39 21 28 18
29 31 23 18 35 26 19 31 19
PAHs CFDA-AM-48 hr exposure
Naphthalene Phenanthrene Pyrene
16 14 26 47 43 59 56 33 25
20 52 26 30 25 60 36 33 38
38 37 34 31 21 14 5 25 14
35 35 43 30 18 17 22 25 27
36 27 34 31 23 45 35 48 16
8 13 16 38 42 43 26 22 26
16 43 36 15 44 86 18 25 48
24 22 26 13 18 15 22 16 17
Benzo (a)pyrene 1,5-/1,7-Dimethylphenanthrene 2,6-Dimethylnaphthalene
21 56 29 49 32 58 81 36 70
60 56 59 32 35 38 23 20 54
26 27 42 10 5 13 27 21 50
20 25 34 40 56 58 10 18 45
20 19 25 18 30 32 17 28 29
34 53 92 22 29 16 37 59 78
22 11 84 53 15 27 33 20 43
30 26 32 23 21 40 24 29 37
PAHs mBCI-24 hr exposure
Naphthalene Phenanthrene Pyrene
14 14 17 19 21 20 20 21 19
12 15 12 17 26 15 16 16 17
18 15 14 11 16 19 18 16 11
18 16 12 19 15 19 20 22 21
16 16 11 23 16 18 13 23 22
7 17 14 23 18 17 17 14 14
22 20 19 16 23 21 15 20 19
14 12 11 21 9 15 21 17 18
Benzo( a)pyrene 2,6-Dimethylnaphthalene 1,5-/1,7-Dimethylphenanthrene
14 24 20 23 13 15 17 18 19
18 16 19 17 18 19 13 18 19
14 16 18 20 16 19 21 23 16
17 21 19 18 19 14 24 18 22
19 16 23 21 12 15 21 17 20
21 21 23 21 12 22 22 18 20
15 16 25 9 23 24 27 16 23
16 13 23 20 16 16 20 21 26
PAHs mBCI-48 hr exposure
Naphthalene Phenanthrene Pyrene
18 20 17 18 17 17 19 17 13
15 27 19 11 15 15 14 15 13
18 13 14 11 13 9 9 14 16
22 14 21 12 15 12 19 22 14
18 19 17 15 17 9 19 13 6
15 21 11 19 14 14 19 13 12
20 16 22 20 14 18 11 13 10
13 15 22 10 19 17 5 12 17
Benzo( a)pyrene 2,6-Dimethylnaphthalene 1,5-/1,7-Dimethylphenanthrene
13 20 15 15 13 17 19 17 14
18 12 10 7 12 16 16 15 14
10 12 11 15 18 17 17 14 16
16 12 12 13 14 16 17 5 14
14 12 16 15 18 15 13 13 20
10 12 19 15 16 18 18 13 21
16 26 21 32 18 22 14 22 15
13 11 17 19 19 10 9 16 15
Coppper Control
AB-24 hr exposure Negative Control
37 38 43 34 32 38 35 45 49
27 40 35 34 39 41 39 39 46
41 37 36 36 40 32 44 49 49
39 38 49 42 34 35 40 40 50
40 35 41 37 38 39 38 49 47
38 40 39 37 36 35 33 46 42
36 43 30 44 35 41 49 46
21 23 24 24 33 27 44 49
39 44
Coppper Control
AB-48 hr exposure Negative Control
28 29 29 32 35 33 44 31 39
36 36 31 34 31 28 40 39 41
32 32 29 33 30 28 38 38 34
34 34 34 32 26 38 33 31 39
32 37 36 33 43 36 36 29 33
31 40 32 31 42 29 34 31 39
28 36 28 27 42 30 34 48
0 26 29 29 33 28 26 38
33 38
CFDA-AM-24 hr exposure Negative Control
5 15 23 34 14 12 25 56 65
3 21 35 14 8 19 23 50 53
6 13 36 36 8 17 16 59 57
9 9 19 42 7 5 64 40 53
0 6 11 27 5 11 57 59 56
9 13 19 27 6 8 54 50 43
12 7 10 14 6 7 50 50
5 6 9 4 5 7 49 50
50 54
Coppper Control
CFDA-AM-48 hr exposure Negative Control
11 13 26 15 21 13 25 56 65
18 21 7 15 11 12 23 50 53
11 12 10 17 11 7 16 59 57
11 21 10 2 9 5 64 40 53
7 4 3 4 2 1 57 59 56
7 7 4 3 2 7 54 50 43
6 2 4 8 5 1 50 50
0 4 8 4 10 4 49 50
50 54
Coppper Control
mBCI-24 hr exposure Negative Control
16 21 19 14 18 9 16 25 24
27 15 21 16 18 18 19 20 25
21 16 21 16 21 18 17 19 22
16 14 18 16 18 19 21 23 22
14 20 19 23 22 11 24 22 25
19 21 19 16 19 17 16 21 24
12 19 19 11 15 12 19 23
15 10 10 8 13 12 27 21
19 25
Coppper Control
mBCI-48 hr exposure Negative Control
13 13 10 14 25 12 13 21 25
12 12 16 14 16 10 20 13 19
13 17 17 19 17 13 11 20 19
11 15 10 15 14 11 17 21 20
13 13 17 11 17 16 17 21 23
16 7 16 16 19 13 10 16 22
14 12 8 11 12 14 22 23
10 6 13 6 10 9 21 25
22 26
